Recently, TOX was revealed its crucial role in tumor‐specific T cell differentiation and CD8+ T cell exhaustion, highlighting a potential biomarker for response prediction or enhancement of cancer immunotherapy.21, 22. The gene discussed is TOX; the disease is cancer.